165 related articles for article (PubMed ID: 29880037)
1. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
2. High expression of SRY-box transcription factor 30 associates with well differentiation, absent lymph node metastasis and predicts longer survival in nonsmall-cell lung cancer patients.
Liu C; Liu Y; Tian J; Zhang S; Li X; Zhai X; Feng Q
Medicine (Baltimore); 2020 May; 99(20):e20122. PubMed ID: 32443323
[TBL] [Abstract][Full Text] [Related]
3. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
4. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
Peng H; Luo Y; Wu J; Yin W
J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
[TBL] [Abstract][Full Text] [Related]
5. SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.
Hao X; Han F; Ma B; Zhang N; Chen H; Jiang X; Yin L; Liu W; Ao L; Cao J; Liu J
J Exp Clin Cancer Res; 2018 May; 37(1):111. PubMed ID: 29855376
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activation.
Tao J; Liu Z; Wang Y; Wang L; Yin G; Yang W; Tu K; Liu Q
Int J Biol Macromol; 2019 Jan; 121():214-222. PubMed ID: 30312695
[TBL] [Abstract][Full Text] [Related]
7. High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma.
Han F; Liu W; Xiao H; Dong Y; Sun L; Mao C; Yin L; Jiang X; Ao L; Cui Z; Cao J; Liu J
Sci Rep; 2015 Sep; 5():13630. PubMed ID: 26330328
[TBL] [Abstract][Full Text] [Related]
8. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
Bao Y; Liu X; Liu Y; Wang S; Wu B
Surg Oncol; 2019 Sep; 30():63-71. PubMed ID: 31500788
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of SRY-box containing gene family member
Zhou JD; Wang YX; Zhang TJ; Li XX; Gu Y; Zhang W; Ma JC; Lin J; Qian J
Clin Epigenetics; 2018; 10():92. PubMed ID: 30002740
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
[TBL] [Abstract][Full Text] [Related]
11. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
[TBL] [Abstract][Full Text] [Related]
12. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
13. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
[TBL] [Abstract][Full Text] [Related]
14. SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer.
Han F; Liu WB; Li JJ; Zhang MQ; Yang JT; Zhang X; Hao XL; Yin L; Mao CY; Jiang X; Cao J; Liu JY
Endocr Relat Cancer; 2019 Mar; 26(3):303-319. PubMed ID: 30608899
[TBL] [Abstract][Full Text] [Related]
15. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
Liu Y; Wang W; Li Y; Huang Y
Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
[TBL] [Abstract][Full Text] [Related]
16. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
17. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
18. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
19. Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
Wu D; Lin J; Zhu Y; Zhang H; Zhong Y
Med Sci Monit; 2019 Jul; 25():5289-5298. PubMed ID: 31310599
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
Shi C; Sun L; Liu S; Zhang E; Song Y
Med Sci Monit; 2020 Mar; 26():e921087. PubMed ID: 32147666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
